Leadership Team
Meet iSpecimen's experienced leadership team with a shared commitment to our mission.
Tracy Wilson Curley
Interim Chief Executive Officer & Chief Financial Officer
Tracy is an experienced, results-oriented business builder focused on leading iSpecimen’s vision for progressive financial performance, expansion and growth in today’s dynamic healthcare and biotechnology research markets.
Tracy brings three decades of experience in public accounting and corporate finance for both publicly traded companies and emerging companies like iSpecimen. Before joining iSpecimen, Tracy served as a partner at CohnReznick LLP, a national accounting firm, where she led the creation and development of an emerging markets commercial audit practice team focused on recruiting and providing audit services to private and public emerging growth companies in the technology and life sciences industries. Earlier, and as a partner at Marcum LLP, a national accounting firm, Tracy led the northeast regional high-tech practice for the firm with a focus on expanding the client base to provide a full range of accounting, tax and advisory services for private and public emerging growth companies in high tech industries such as technology, life sciences and advanced manufacturing. Tracy has also served as a partner at Moody, Famiglietti & Andronico, LLP (MFA), a proactive, Boston-based consulting firm with national and global reach, where she led the creation and development of a public company audit practice focused on recruiting and providing audit services to public emerging growth companies.
Tracy received her Master of Accountancy and Bachelor of Science in Business Administration with a concentration in accounting from Kansas State University. She also attended the United States Military Academy. She is a certified public accountant licensed in the Commonwealth of Massachusetts.
Tracy Wilson Curley
Chief Executive Officer
Leslie Hoyt
Chief Operating Officer
Leading Operations for iSpecimen, Leslie utilizes her 30+ years as a COO in healthcare, and focuses on operational efficiency, change management, and building strong relationships in and out of the company. She is responsible for the teams of professionals working on order fulfillment, supplier relationships, laboratory and distribution services, customer service, and human resources.
Leslie started her career on the provider-side of healthcare. As COO of the CareGroup PSN, the value-based contracting organization for 9 major hospitals and their physicians, she built cross hospital programs to improve the quality of care and ensure financial success in a capitated environment.
As VP and US Healthcare practice lead at Sapient (now Publicis Sapient), a Global IT consultancy, her passion for leveraging technology to improve the quality of healthcare was realized. She used that experience in technology and business to design and manage Dovetail Health, a healthcare technology company addressing home-based medication adherence following high-risk admissions, which was ultimately sold to Optum. As SVP of Optum, Leslie managed major strategic partners, leveraging UHG assets to create innovative health solutions that benefited both parties.
Leslie excels in start-up, high growth settings, and more recently has been a COO for biotech companies in the Boston area such as GNS (now Aitia), Olaris, and Naveris.
Leslie lives in Lexington, MA and enjoys playing tennis, pickleball and golf.
Leslie Hoyt
Chief Operating Officer
Evan Cox
Vice President of Product Management
Evan brings nearly 20 years of Product Management and leadership experience to iSpecimen. In his role at iSpecimen, Evan is responsible for creation and management of the long-term roadmap and strategy plan for our industry leading iSpecimen Marketplace application. Prior to joining iSpecimen, Evan held several key senior management roles at Definitive Healthcare Corp., a provider of healthcare commercial intelligence, most recently as Associate Vice President, where he led the product management team. Before that, he held multiple product strategy and decision support roles at Change Healthcare, a healthcare technology company, where he focused on artificial intelligence and natural language processing to streamline existing workflows.
In addition, Mr. Cox co-founded DSE Analytics, a company that used natural language processing to integrate qualitative and quantitative information available on Consumer Assessment of Healthcare Providers and Systems (CAHPS) surveys to deliver providers deep insights into their satisfaction scores. He also served as Senior Product Manager of Data Analytics and Research at Press Ganey Associates and Product Lead of Clinical Data Management at WebMD.
Evan Cox
Senior Vice President of Strategy & Innovation
Brielan Smiechowski
Senior Vice President of Business Development
Brielan leads iSpecimen's business development and sales. She and her team are focused on helping scientists and their organizations procure the biospecimens necessary to advance their research and technologies.
Brielan Smiechowski brings over 15 years of experience in Life Sciences and Healthcare. She is a technical advisor for the City of Gloucester Health Department and lectures at the University of Southern California. She is a partner with Social Justice Partners Los Angeles and a board member of the nonprofit Eat Move Meditate. Previously, Brielan was a director at Veeva and has also held business development and research roles at HealthVerity, Aitia, PrecisionAQ, and Icon PLC. Brielan received her MSc in Epidemiology from McGill University and BS in Biological Sciences from Arkansas State University.
Brielan Smiechowski
Senior Vice President of Business Development
Annette Arnold
Vice President of Sales & Business Development
Annette is responsible for driving and managing all aspects of company sales and business development. In this position, she applies her strategic vision as well as her skills in negotiation, facility management (FM) and management. Additionally, she plays a key role in analyzing and developing the supply partner network in order to meet the demands of iSpecimen’s rapidly expanding customer base.
Annette has over 20 years of experience working in sales. Before joining iSpecimen, Annette was Manager of Business Development at Folio Conversant. There, she was responsible for supporting and growing business within existing accounts, and developing new accounts, through direct customer sales. Prior to Folio Conversant, she moved from Business Administrator to Client Account Manager at Biblioteca. For over a decade, Annette and her teams have established solid relationships with R&D groups, grown business revenue substantially, and streamlined project workflows for vital accounts. Annette holds an AS in Computer Science from Keene State College.
Annette Arnold
Vice President of Sales & Business Development
Carly Lejnieks
Vice President of Marketing
Carly and her team are focused on bringing the unique iSpecimen offering to life science customers who are seeking streamlined, compliant solutions for procuring archived pathology, banked, and prospective or custom-collected human biospecimens. The team is also focused on engaging new partners interested in joining the iSpecimen network, enabling deep and far-reaching access to millions of human biospecimens and patients that have consented to donate them.
Carly has led marketing strategies, integrated programs, and high-growth initiatives for Life Science organizations for more than 20 years. Before joining iSpecimen, she worked as a marketing consultant for more than a decade serving clients in the healthcare and life science industries. Most recently, she managed global, digital marketing and eCommerce programs responsible for driving double-digit growth in the cell culture consumables division of Thermo Fisher Scientific.
Carly Lejnieks
Vice President of Marketing
David Wages, Md, Phd
Chief Medical Officer
David is responsible for ensuring that iSpecimen meets the medical research needs of customers. This includes ensuring that specimens are of the highest quality and that iSpecimen technology will continue to meet the increasingly sophisticated needs of the academic, pharmaceutical, and government research communities.
Prior to joining iSpecimen, David served as Senior Medical Director at Quintiles, the world’s largest clinical research organization, where he supported both large pharmaceutical companies as well as smaller biotech organizations in a wide variety of clinical oncology programs. David has worked in both start-up biotechs and large pharma. David began his career working on the clinical development of novel drug-device combinations for blood decontamination at Cerus Corporation. He then worked on clinical trials at Wyeth that led to the development of Xyntha®, a drug used to treat hemophilia. After a brief stint assisting institutional investors on healthcare technology opportunities at Leerink-Swann’s Medacorp, David then moved on to ARIAD Pharmaceuticals where he turned to cancer research, working on ARIAD’s mTOR inhibitor for solid tumors as well as initiating ARIAD’s phase I trial for chronic myeloid leukemia drug, Iclusig®. David next joined EMD Serono where he worked on phase I-III trials of immune-agents for oncology. David holds an MD and PhD from the University of Virginia School of Medicine where he focused on the basic science of oncology. He then completed a residency at the University of California, San Francisco and a fellowship in hematopathology at Boston’s Beth Israel hospital.
David Wages, MD, PhD
Chief Medical Officer
Board of Directors
The following individuals sit on iSpecimen's board of directors
Andrew Ross
Board Member
Theresa Mock
Board Member
Steven Gullans
Board Member
John L. Brooks III
Board Member
Elizabeth Graham
Board Member